Advanced search
Publication Cover
OncoTargets and Therapy Volume 12, 2019 - Issue
Submit an article Journal homepage
33
Views
5
CrossRef citations to date
0
Altmetric
Case Report

Durable Molecular Remission in a Lymphoid BP-CML Patient Harboring T315I Mutation Treated with Anti-CD19 CAR-T Therapy

Lu Zhou1 Hematology Department, Affiliated Hospital of Nantong University, Nantong, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-0148-6618
ORCID Icon,
Huiping Shi2 Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA
,
Wenyu Shi1 Hematology Department, Affiliated Hospital of Nantong University, Nantong, People’s Republic of China
,
Li Yang1 Hematology Department, Affiliated Hospital of Nantong University, Nantong, People’s Republic of China
,
Yaping Zhang1 Hematology Department, Affiliated Hospital of Nantong University, Nantong, People’s Republic of China
,
Mengqi Xu1 Hematology Department, Affiliated Hospital of Nantong University, Nantong, People’s Republic of China
,
Xiufang Chen1 Hematology Department, Affiliated Hospital of Nantong University, Nantong, People’s Republic of China
,
Yanv Zhu1 Hematology Department, Affiliated Hospital of Nantong University, Nantong, People’s Republic of China
,
Hui Mu1 Hematology Department, Affiliated Hospital of Nantong University, Nantong, People’s Republic of China
,
Xiaochun Wan3 Shenzhen Bin De Bio Tech Co. Lid, Shenzhen, People’s Republic of China
,
Zhonghua Yang3 Shenzhen Bin De Bio Tech Co. Lid, Shenzhen, People’s Republic of China
,
Ying Zeng3 Shenzhen Bin De Bio Tech Co. Lid, Shenzhen, People’s Republic of ChinaCorrespondence[email protected]
&
Hong Liu1 Hematology Department, Affiliated Hospital of Nantong University, Nantong, People’s Republic of ChinaCorrespondence[email protected]
 show all
Pages 10989-10995 | Published online: 13 Dec 2019

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Lulu Wang, Li Li, Rongrong Chen, Xianbo Huang & Xiujin Ye. (2021) Understanding and Monitoring Chronic Myeloid Leukemia Blast Crisis: How to Better Manage Patients. Cancer Management and Research 13, pages 4987-5000.
Read now

Articles from other publishers (4)

Stephanie Sembill, Maria Ampatzidou, Sonali Chaudhury, Michael Dworzak, Krzysztof Kalwak, Axel Karow, Alexander Kiani, Manuela Krumbholz, Maaike Luesink, Nora Naumann-Bartsch, Barbara De Moerloose, Michael Osborn, Kirk R. Schultz, Petr Sedlacek, Fiorina Giona, Christian Michel Zwaan, Hiroyuki Shimada, Birgitta Versluijs, Frederic Millot, Nobuko Hijiya, Meinolf Suttorp & Markus Metzler. (2023) Management of children and adolescents with chronic myeloid leukemia in blast phase: International pediatric CML expert panel recommendations. Leukemia 37:3, pages 505-517.
Crossref
John Joson Ng & S. Tiong Ong. (2022) Therapy Resistance and Disease Progression in CML: Mechanistic Links and Therapeutic Strategies. Current Hematologic Malignancy Reports 17:6, pages 181-197.
Crossref
Binoy Yohannan & Binsah George. (2022) B-Lymphoid Blast Phase–Chronic Myeloid Leukemia: Current Therapeutics. International Journal of Molecular Sciences 23:19, pages 11836.
Crossref
Ya-Ching Hsieh, Kristina Kirschner & Mhairi Copland. (2021) Improving outcomes in chronic myeloid leukemia through harnessing the immunological landscape. Leukemia 35:5, pages 1229-1242.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.